Ciprofloxacin or rifampin was significantly (P < 0.05) more effective than vancomycin or the combination of vancomycin plus gentamicin for the treatment of Staphylococcus epidermidis experimental endocarditis. There were no significant differences in efficacy among any of the combinations of antimicrobial agents that included ciprofloxacin or rifampin. One animal treated with rifampin alone and one treated with the combination of vancomycin, rifampin, and gentamicin were found to be infected with rifampin-resistant strains of S. epidermidis during therapy. Resistant subpopulations of S. epidermidis were not detected during therapy with any other antimicrobial agent used alone or in combination. Ciprofloxacin alone or in combination with rifampin was effective therapy against S. epidermidis experimental endocarditis.
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Staphylococcus epidermidis is the most common causative agent of prosthetic valve endocarditis (4, 9, 11, 15, 16) . Strains of S. epidermidis recovered from patients with prosthetic valve endocarditis are usually resistant to betalactam antimicrobial agents, and the mortality rate for patients with this infection is very high, 58 to 74% (9) . The current antimicrobial therapy recommended for patients with methicillin-resistant S. epidermidis prosthetic valve endocarditis consists of administration of vancomycin either alone or in combination with either rifampin or gentamicin or administration of all three agents simultaneously (9) . The use of these antimicrobial agents is costly and may be associated with significant adverse or toxic effects.
Ciprofloxacin is effective in vitro against a wide variety of gram-positive and gram-negative microorganisms, including S. epidermidis (2, 6) . Accordingly, ciprofloxacin might be useful therapy for patients with S. epidermidis infective endocarditis. The purpose of this study was to determine the efficacy of ciprofloxacin alone or in combination with rifampin for treatment of S. epidermidis experimental endocarditis and to compare the results with those resulting from therapy with other antimicrobial regimens.
MATERIALS AND METHODS
In vitro studies. Eighteen strains of S. epidermidis isolated from patients with infective endocarditis seen at the Mayo Clinic were studied. A macrodilution method was used for in vitro susceptibility testing (19) . The MIC was defined as the lowest concentration of antimicrobial agent in broth without visible growth of staphylococci. The MBC was determined by subculturing 100 RI of nonsupplemented Mueller-Hinton broth from the control tube, the first tube containing growth, and from all tubes without visible growth and was defined as the lowest concentration of antibiotic that killed .99.9% of the original inoculum.
Of these 18 strains, 1 strain was selected for in vitro studies and for use in an experimental endocarditis model. This strain was chosen because of its ability to consistently produce experimental endocarditis in rabbits.
Killing curves were performed with antibiotic singly or in combination by using an inoculum size of >106 CFU of * Corresponding author. staphylococci per ml (19) . Tests were performed in triplicate, and the results were expressed as the mean value.
Animal studies. Experimental aortic valve endocarditis was established in a total of 119 New Zealand White rabbits (weight, >2 kg) by modifications of the methods described by Garrison and Freedman (8) . Briefly, animals were anesthetized with a mixture of ketamine and xylazene injected intramuscularly (i.m.). An incision was made in the neck, and the right carotid artery was exposed. The artery was ligated distally, and a sterile polyethylene catheter (PE 90; Intramedic; Clay Adams) was inserted into the artery through a small incision and advanced proximally across the aortic valve into the left ventricle. A pressure-sensitive monitoring device was attached to the distal end of the catheter to ensure that the catheter tip crossed the aortic valve and entered the left ventricle. The end of the catheter was sealed and tied to the carotid artery, and the would was closed over the catheter with surgical clips. The catheter was left in place throughout the experiment. Twenty-four hours after insertion of the catheter, 1 ml of broth containing 107 to 108 CFU of S. epidermidis per ml was injected into a peripheral ear vein. The presence of endocarditis was confirmed by a blood culture that yielded staphylococci that were obtained 24 h after infection and before the initiation of antimicrobial therapy.
Antimicrobial therapy was initiated 24 h after intravenous (i.v.) injection of S. epidermidis. Animals were placed into treatment groups as follows: (i) For the control group, nine animals received no antimicrobial therapy. (ii) For the van- >8 ,ug/ml; gentamicin, 0.25 and 1.0 ,ug/ml; vancomycin, 0.5 and 1.0 ,ug/ml; ciprofloxacin, 0.25 and 1.0 ,ug/ml; and rifampin, 0.25 and 0.5 p,g/ml, respectively. Table 2 shows the results of time-kill curves. The magnitude of in vitro killing was greatest with the combination of ciprofloxacin and rifampin.
The concentrations of antimicrobial agents in the serum of uninfected animals are shown in Table 3 . Among infected animals on day 2 of therapy, the mean concentrations in serum at 0.5 h were 62.5 ± 6.2 jig of vancomycin per ml, 3 .0 ± 0.6 ,ug of gentamicin per ml, and 3.8 ± 0.9 ,ug of ciprofloxacin per ml and 4.2 ± 0.6 ,ug of rifampin per ml.
The results of treatment of S. epidermidis experimental endocarditis are shown in Table 4 . Treatment with ciprofloxacin or rifampin was significantly (P < 0.05) more effective than treatment with vancomycin alone or the combination of vancomycin plus gentamicin. There were no significant differences in the effects of therapy among any of the combinations of antimicrobial agents that included rifampin compared with the effects of treatment with ciprofloxacin or rifampin administered alone. The number of animals with sterile cardiac valve vegetations was greater (P < 0.03) among animals treated with combinations of antimicrobial agents that included rifampin than among animals treated with a single drug alone or with the combination of vancomycin and gentamicin.
In one animal treated with rifampin alone and in one animal treated with the combination of vancomycin, gentamicin, and rifampin, resistance to rifampin (MIC, >8 ,ug/ml) was developed during therapy. Subpopulations of S. epidermidis resistant to other antimicrobial agents were not detected among any of the other treatment groups. There was no cross-resistance of rifampin-resistant strains to the other antimicrobial agents used in our study.
DISCUSSION
In our study, ciprofloxacin or rifampin was the most effective single agent for the treatment of S. epidermidis experimental endocarditis, and either agent alone was more effective (P < 0.05) than vancomycin or the combination of gentamicin and vancomycin. Galetto et al. (7) and Kobasa and colleagues (13) have reported that the combination of vancomycin and gentamicin is more effective therapy for S. epidermidis experimental endocarditis than is vancomycin alone. In our study, the combination of vancomycin and gentamicin was no more effective therapy than was vancomycin alone.
The results of our study were also in agreement with previously published studies which described the in vitro activity of rifampin and the efficacy of rifampin therapy for S. epidermidis experimental endocarditis (1, 10, 13, 14, 17, 18 Rifampin-resistant strains of S. epidermidis were detected in only two animals (one treated with rifampin alone and one treated with the combination of rifampin, vancomycin, and gentamicin). The emergence of rifampin-resistant strains of S. epidermidis during treatment of experimental endocarditis in rabbits and during treatment of S. epidermidis prosthetic valve endocarditis in humans has been observed previously (1, 9, 11, 14, 18) . In these reports, rifampin-resistant strains occurred more frequently when rifampin was administered alone rather than in combination with other antimicrobial agents. The results of these experimental and human studies suggest that rifampin should not be used alone for the treatment of S. epidermidis endocarditis.
Katz and associates (12) (9, 11) . Ciprofloxacin and rifampin are both well absorbed from the gastrointestinal tract, and the administration of oral dosages of ciprofloxacin has resulted in concentrations in serum similar to those observed in our study following parenteral administration (3) . If 
